Delivery Order SPE2DB22D6029-SPE2DB25FLWAY
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $4,929.73 to AmerisourceBergen Drug Corp for Venofer 100 mg/5 ml vials, with an ultimate completion date of July 24, 2025. The contract employs firm fixed pricing with no set-aside designation, indicating open competitive award. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly supporting military and...
- The Defense Logistics Agency awarded a delivery order valued at $2,154.32 to AmerisourceBergen Drug Corp for the supply of Venofer 100 mg/5 mL vials on August 27, 2025, with completion scheduled for August 28, 2025. This firm fixed-price delivery order represents a competitively awarded, non-set-aside procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office location in the same...
- The Defense Logistics Agency awarded a $20,405.80 delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Venofer 200 mg/10 mL vials. This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 18, 2025. The place of performance is located in Conshohocken, Pennsylvania, which serves as AmerisourceBergen's corporate headquarters. This delivery order is a child contract issued under the company's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 15, 2025, for the supply of Venofer 100 mg/5 mL vials with a ceiling value of $1,502.16 and firm fixed pricing. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The award was made without set-aside designation through competitive procurement,...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Venofer 100 mg/5 ml vials. The $3,042.87 firm fixed price contract has an ultimate completion date of April 18, 2024. Amerisourcebergen Drug Corp is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, leveraging its parent company's extensive distribution network. This order is placed...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a $12,628.53 firm fixed-price delivery order by the Defense Logistics Agency on August 29, 2025, for the supply of Injectafer 750 mg/15 mL vials. This non-set-aside, competitively awarded contract represents a child order under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through...
- AmerisourceBergen Drug Corp has been awarded a $6,242.40 delivery order by the Defense Logistics Agency's Medical Supply Chain for the procurement of Infed 100 mg/2 mL vials. This firm fixed-price contract, issued on July 11, 2025, with an ultimate completion date of July 14, 2025, represents a non-competitive delivery against AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The product will be performed and delivered from the contractor's...
- The Defense Logistics Agency awarded a delivery order valued at $12,066.50 to AmerisourceBergen Drug Corp for the supply of Injectafer 750 mg/15 ml vials. This competitive award, issued on August 8, 2025, with an ultimate completion date of August 11, 2025, represents a firm fixed price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical...
- This federal contract award is for the delivery of Venofer 100 mg/5 ml vials to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on May 20, 2023, with a total ceiling value of $4,239.04. The contract is a Firm Fixed Price Delivery Order with a completion date of May 22, 2023. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., which has a significant Indefinite Delivery...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,293.72, is for the supply of VENOFER 100 MG/5 ML VIAL 5ML, a medication used in the treatment of iron deficiency anemia. The contract has an ultimate completion date of April 30, 2024. This delivery order is issued under AmerisourceBergen's existing...
- SPE2DB22D6029Indefinite Delivery Contract
- SPE2DB22D6029-SPE2DB25FLWAYDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $8,440.81 to AmerisourceBergen Drug Corp for the supply of Venofer 100 mg/5 mL vials. This competitively awarded, firm fixed-price contract was issued on September 18, 2025, with an ultimate completion date of September 19, 2025. The product will be performed and delivered from AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime vendor agreement running through December 2026 that enables the company to supply pharmaceutical products and medical supplies to support military healthcare programs globally. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement through the Defense Logistics Agency's Medical Supply Chain. The company's extensive federal contract portfolio demonstrates its capability to fulfill open competition requirements across a wide range of pharmaceutical products and medical supplies. As a non-set-aside award, this delivery order reflects AmerisourceBergen's competitive standing among federal contractors and its role in supporting military and veteran healthcare systems with essential pharmaceutical commodities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.4k | 9/18/25 |